AIP
GRTX

Ameritas Investment Partners’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Ameritas Investment Partners’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-750
Closed -$7K – 3267
2021
Q1 		$7K Hold
750
– – ﹤0.01% 2958
2020
Q4 		$8K Buy
750
+605
+417% +$6.62K ﹤0.01% 2894
2020
Q3 		$1K Hold
145
– – ﹤0.01% 3088
2020
Q2 		$1K Hold
145
– – ﹤0.01% 3053
2020
Q1 		$1K Hold
145
– – ﹤0.01% 3011
2019
Q4 		$2K Buy
+145
New +$1.77K ﹤0.01% 2983

Other funds holding GRTX

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Ameritas Investment Partners's GRTX Position: Q2 2021 in Review

Ameritas Investment Partners sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2021, closing a stake of 750 shares — an estimated $7K sold.

Ameritas Investment Partners first reported a position in GRTX in Q4 2019 and held it in 6 quarters. The position peaked at $8K in Q4 2020. 47 funds tracked by Wall St. Rank hold GRTX as of Q2 2021.

  • Ameritas Investment Partners reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 750 Galera Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $7K.
  • Ameritas Investment Partners first reported a position in Galera Therapeutics, Inc. Common Stock in Q4 2019 and held it in 6 quarters.
  • Ameritas Investment Partners's Galera Therapeutics, Inc. Common Stock position peaked at $8K in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.